InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Klotman Mary E.. Director active across 1 company, notably AMGEN INC. Cumulatively, 2 reports have been logged. Activity tracked since 31 May 2024. The latest transaction was filed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations